Collaboration Blends Advanced Cloud Technologies, Open-Source Collaboration, and Data Science Integration to support UCB’s development pipeline

BRUSSELS and SAN FRANCISCO, May 19, 2025 /PRNewswire/ — UCB, a global biopharmaceutical company, and Domino Data Lab, provider of a leading data science platform trusted by the world’s largest enterprises, today announced a strategic collaboration aimed at modernizing a Statistical Computing Environment (SCE) for the life sciences industry. This joint effort aims to transform the legacy SCE into unified, scalable, and flexible platforms to meet the evolving demands of clinical research, regulatory compliance, and efficient data analysis.

The two companies will work together to implement a modern cloud-enabled environment that integrates diverse analytical tools, such as SAS, R, and Python, within a unified framework. This platform will leverage Domino’s expertise in cloud technologies and open-source support, combined with UCB’s deep clinical research and regulatory knowledge. Together, this effort aims to enhance research capabilities and maintain compliance with industry standards like GxP, FDA 21 CFR Part 11, and GDPR.

“At UCB, we believe that innovation thrives through collaboration, and this partnership exemplifies our commitment to evolving and pushing the boundaries of what’s possible in life sciences. By harnessing advanced technologies to modernize our statistical computing environment and combining our expertise with Domino’s cutting-edge platform, we aim to accelerate the development of innovative therapies for people living with severe diseases,” said Mike Branson, SVP, Head Biometrics and Data Science, UCB. He added, “This new SCE will embed critical metadata and workflow management to enable searchable, responsible data re-use, accelerating our cutting-edge Data Science and enabling more efficient drug development and evidence-based decision making.”

The collaboration is aligned with UCB’s broader scientific innovation strategy, which includes leveraging pathways, populations, and technology platforms to uncover the root biological causes of diseases, deepen understanding of patient populations, and accelerate R&D pipelines.

“We’re proud to partner with UCB to help patients get new therapies faster,” said Nick Elprin, CEO and co-founder of Domino Data Lab. “Together, we aim to lead the way in modernizing Statistical Computing Environments to accelerate clinical development with greater speed, flexibility, and confidence.”

The modernized SCE will bring immediate benefits to researchers, data scientists, and patients by providing streamlined access to state-of-the-art tools. Enhancing UCB’s capabilities in this way should expedite the development of differentiated therapies, offering faster, more tailored treatment options for those living with severe diseases. Additionally, the integration of advanced data science will enable more efficient clinical studies, leveraging large-scale data analysis to enhance predictions about efficacy and tolerability.

This collaboration also emphasizes UCB and Domino’s shared commitment to driving innovation across the life sciences industry. By contributing to initiatives like PHUSE, and the SCE Coalition, the partnership aims to foster open-source principles, challenge industry norms, and establish global standards for efficient and compliant statistical environments. Together, UCB and Domino are not only advancing their own operations but also paving the way for broader industry transformation.

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 9 000 people in approximately 40 countries, the company generated revenue of € 6.1 billion in 2024. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news.

About Domino Data Lab

Domino Data Lab empowers the largest data-driven enterprises to build and operate data science at scale. Domino’s Enterprise Data Science Platform provides an integrated experience encompassing analysis and reporting, collaboration, and governance. With Domino, global enterprises can develop better medicines, grow more productive crops, develop more competitive products, and more. Founded in 2013, Domino is backed by Sequoia Capital, Coatue Management, NVIDIA, Snowflake, and other leading investors. Learn more at domino.ai.

Investor Relations
UCB, Antje Witte
T +32.2.559.94.14
email antje.witte@ucb.com

Head of Global R&D and Business Communications
UCB, Scott Fleming
T +447702777378
email scott.fleming@ucb.com

For Domino Data Lab
David Conner
T +1 415-907-0400
email david.conner@dominodatalab.com 

Forward looking statements

This document contains forward-looking statements, including, without limitation, statements containing the words “potential”, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will”, “continue” and similar expressions. These forward-looking statements are based on current plans, estimates and beliefs of management. All statements, other than statements of historical facts, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial information, expected legal, arbitration, political, regulatory or clinical results or practices and other such estimates and results. By their nature, such forward-looking statements are not guaranteeing future performance and are subject to known and unknown risks, uncertainties, and assumptions which might cause the actual results, financial condition, performance or achievements of UCB, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements contained in this document. Important factors that could result in such differences include but are not limited to: global spread and impacts of wars, pandemics and terrorism, the general geopolitical environment, climate change, changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable terms or within expected timing, costs associated with research and development, changes in the prospects for products in the pipeline or under development by UCB, effects of future judicial decisions or governmental investigations, safety, quality, data integrity or manufacturing issues, supply chain disruption and business continuity risks; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, product liability claims, challenges to patent protection for products or product candidates, competition from other products including biosimilars or disruptive technologies/business models, changes in laws or regulations, exchange rate fluctuations, changes or uncertainties in tax laws or the administration of such laws, and hiring,  retention and compliance of its employees. There is no guarantee that new product candidates will be discovered or identified in the pipeline, or that new indications for existing products will be developed and approved. Movement from concept to commercial product is uncertain; preclinical results do not guarantee safety and efficacy of product candidates in humans. So far, the complexity of the human body cannot be reproduced in computer models, cell culture systems or animal models. The length of the timing to complete clinical trials and to get regulatory approval for product marketing has varied in the past and UCB expects similar unpredictability going forward. Products or potential products which are the subject of partnerships, joint ventures or licensing collaborations may be subject to disputes between the partners or may prove to be not as safe, effective or commercially successful as UCB may have believed at the start of such partnership. UCB’s efforts to acquire other products or companies and to integrate the operations of such acquired companies may not be as successful as UCB may have believed at the moment of acquisition. Also, UCB or others could discover safety, side effects or manufacturing problems with its products and/or devices after they are marketed. The discovery of significant problems with a product similar to one of UCB’s products that implicate an entire class of products may have a material adverse effect on sales of the entire class of affected products. Moreover, sales may be impacted by international and domestic trends toward managed care and health care cost containment, including pricing pressure, political and public scrutiny, customer and prescriber patterns or practices, and the reimbursement policies imposed by third-party payers as well as legislation affecting biopharmaceutical pricing and reimbursement activities and outcomes. Finally, a breakdown, cyberattack or information security breach could compromise the confidentiality, integrity and availability of UCB’s data and systems. Given these uncertainties, the public is cautioned not to place any undue reliance on such forward-looking statements. These forward-looking statements are made only as of the date of this document, and do not reflect any potential impacts from the evolving event or risk as mentioned above as well as any other adversity, unless indicated otherwise. The company continues to follow the development diligently to assess the financial significance of these events, as the case may be, to UCB. UCB expressly disclaims any obligation to update any forward-looking statements in this document, either to confirm the actual results or to report or reflect any change in its forward-looking statements with regard thereto or any change in events, conditions or circumstances on which any such statement is based, unless such statement is required pursuant to applicable laws and regulations.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ucb-and-domino-data-lab-collaborate-to-modernize-statistical-computing-environment-in-life-sciences-302458732.html

SOURCE Domino Data Lab; UCB

JAKARTA, Indonesia, May 20, 2025 /PRNewswire/ — On May 19, the “Revitalization of Mangroves” China-Indonesia Dialogue on Sustainable Development was held in Jakarta. The event brought together over a hundred guests, including government representatives, experts, scholars, and business leaders from China, Indonesia, Cambodia, Malaysia, and other countries, to explore ecological protection and sustainable development pathways for mangrove ecosystems.

Gao Anming, Editor-in-Chief of China Foreign Languages Publishing Administration, noted that China Foreign Languages Publishing Administration will continue to act as a bridge in promoting mangrove conservation by building a platform for friendly exchange. He emphasized the importance of balancing ecological protection with economic development and showcasing the “green achievements” of China–Indonesia cooperation to the world.

Wang Siping, Cultural Counselor of the Chinese Embassy in Indonesia, stated in his remarks that China and Indonesia have enormous potential for cooperation in mangrove and biodiversity conservation. As 2025 marks the 75th anniversary of the establishment of diplomatic relations between the two countries, China is willing to work with Indonesia to expand collaboration across economic, social, cultural, and ecological sectors, injecting new momentum into the China-Indonesia Comprehensive Strategic Partnership.

Zhao Shibin, General Manager of GD Power under China Energy Investment Corporation (CHN Energy), remarked that ecological protection is not a multiple-choice question, but a necessary answer for the survival of civilization. The expansion of mangrove forests has increased employment opportunities for local communities and bolstered fishery resources. This reflects a shared responsibility for improving livelihoods and strengthens the bonds that unite our shared home.

During the conference, scholars from various countries delivered keynote speeches focused on mangrove conservation, offering valuable insights under the theme “Protecting Mangroves, Safeguarding Our Blue Planet”.

Linda Krisnawati, Senior Environmental Extension Officer, Ministry of Environment of Indonesia, highlighted the multifaceted value of mangrove restoration for marine ecosystems and fisheries. She expressed hope for deeper cooperation with China in technological innovation and talent development. Meas Rithy, Deputy Director of Department of Coastal Zone and Marine Conservation of Ministry of Environment of Cambodia, said that mangrove restoration is not only an environmental goal, but also a symbol of cross-national and cross-sector collaboration. He called on all parties to join hands in reviving mangroves and restoring marine ecosystems to create a green, inclusive, and resilient future.

The event was co-hosted by China International Communications Group, China Energy Investment Corporation, and Indonesia’s State Electricity Company (PT PLN). During the dialogue, youth representatives from China and Indonesia jointly released The Earth’s Lung and the Guard of Coast: Jakarta Initiative on Conservation of Mangroves.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/revitalization-of-mangroves-china-indonesia-dialogue-on-sustainable-development-held-in-jakarta-302459276.html

SOURCE China International Communications Group

BANGALORE, India, May 19, 2025 /PRNewswire/ —

Major Factors

Integration of AI-optimized processing features into consumer and commercial motherboards.Shift in gaming preference toward AMD platforms, pushing brands to diversify their offerings.Rising demand for environmentally sustainable and energy-efficient motherboard designs.Growth of content creation and professional workstation use cases, leading to premium motherboard upgrades.Increasing preference for mini-ITX and compact form factor boards, especially in urban setups.

Claim Your Free Report: https://reports.valuates.com/request/sample/MICR-Othe-0J9/Global_Motherboard_Market

TRENDS INFLUENCING THE GROWTH OF THE GLOBAL MOTHERBOARD MARKET 2025 – 2029

The integration of artificial intelligence into personal computing has started shaping motherboard design and functionality. New motherboards are now being developed to support AI-specific processing units, NPU compatibility, and higher data transfer capacities. This shift toward AI-accelerated workloads is expected to redefine standard motherboard specifications, thus encouraging broader market adoption in both consumer and enterprise segments.

The gaming segment continues to be a cornerstone of motherboard demand. With the release of next-generation games and increasing adoption of high-performance GPUs, gamers are upgrading to motherboards with improved thermal performance, support for higher RAM frequencies, and faster data lanes. The shift from legacy platforms to AMD-based systems among gamers is also creating a dynamic change in motherboard selection trends.

Enterprise demand is projected to remain strong due to ongoing PC refresh cycles in commercial and educational institutions. Organizations are prioritizing infrastructure modernization, particularly in regions shifting to hybrid work models. This drives demand for motherboards tailored to stability, power efficiency, and longer lifecycle support, particularly from OEM vendors.

A strong contributor to motherboard market expansion has been the growing enthusiasm among consumers for custom-built desktop systems. Enthusiasts and hobbyists continue to drive demand for motherboards that offer flexibility, enhanced overclocking capabilities, and modular compatibility. This trend has not only revived aftermarket component sales but also pushed manufacturers to release more consumer-focused variants across mid-range and premium segments.

The market has seen a sharp response to the introduction of new-generation processors from key semiconductor players. These launches compel users to upgrade their motherboard to ensure compatibility with newer chipsets, PCIe versions, and RAM standards. In turn, this compatibility requirement has played a vital role in fueling upgrade cycles, especially among gamers, developers, and performance users.

The return of cryptocurrency mining activities has significantly influenced motherboard consumption. Mining setups often require multiple GPU support and high-durability motherboards, prompting the development and uptake of products optimized for sustained high-load performance. This renewed demand from crypto-miners has temporarily reshaped buying behavior and encouraged motherboard manufacturers to cater to niche mining requirements.

Unlock Insights: View Full Report Now!  https://reports.valuates.com/market-reports/MICR-Othe-0J9/global-motherboard

MOTHERBOARD MARKET SHARE

Asia-Pacific continues to remain the dominant region in terms of motherboard demand, driven by manufacturing hubs, tech-savvy consumers, and a strong PC-building culture. North America and Europe follow, with demand linked to gaming, AI PC deployment, and enterprise refresh cycles. Meanwhile, Southeast Asia is emerging as a high-growth region due to expanding digital infrastructure and rising disposable incomes, drawing greater attention from global motherboard brands aiming to localize production and marketing strategies.

Claim Yours Now! https://reports.valuates.com/api/directpaytoken?rcode=MICR-Othe-0J9&lic=single-user

Companies in Market and Their Potential Market Share

Intel remains a central player through its chipset and processor compatibility ecosystems, especially in the commercial and entry-level markets. The company’s strong OEM partnerships ensure continued relevance across various user segments.AMD, benefiting from its increasing adoption in gaming and creator communities, is steadily expanding its motherboard influence, particularly through support for high-performance gaming and multitasking workloads.NVIDIA, although not a direct motherboard manufacturer, plays a crucial role in influencing motherboard designs through its GPU requirements. Motherboards optimized for high-end NVIDIA GPUs continue to be in demand, making the company’s hardware roadmap a significant market driver.

What this Report Offers:

This report provides an in-depth analysis of the global motherboard market, covering a comprehensive range of data and insights to support strategic decision-making.It includes detailed coverage of worldwide motherboard shipment volumes from 2021 to 2029, quarterly shipment trends from 1Q23 to 4Q25, and the ratio of motherboard shipments to desktop PC shipments during the same period.The report also presents regional shipment volumes and shares from 2021 to 2025, along with expert intelligence insights, clearly defined research scope, and terminology explanations.In addition to our standard offerings, we provide customized reporting services tailored to your unique business needs. These project-based solutions deliver data-driven insights aligned with your strategic objectives, helping you make informed decisions with precision.

Purchase Chapters: https://reports.valuates.com/request/chaptercost/MICR-Othe-0J9/Global_Motherboard_Market

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!

–          The global market for Server Motherboard was estimated to be worth US$ 48910 million in 2023 and is forecast to a readjusted size of US$ 61680 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030.
–          Notebook Motherboard Market
–          The global market for PCIe 4.0 Protocol Computer Motherboard was estimated to be worth US$ 10210 million in 2023 and is forecast to a readjusted size of US$ 14460 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030.
–          Server System and Server Motherboard Market
–          The global market for Industrial Robot Embedded Motherboard was valued at US$ 143 million in the year 2024 and is projected to reach a revised size of US$ 266 million by 2031, growing at a CAGR of 9.3% during the forecast period.
–          Motherboard Sound Card Market

DISCOVER OUR VISION: VISIT ABOUT US!

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that’s why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

GET A FREE QUOTE

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335

Website: https://reports.valuates.com

Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Facebook: https://www.facebook.com/valuatesreports/
YouTube: https://www.youtube.com/@valuatesreports6753

https://www.facebook.com/valuateskorean
https://www.facebook.com/valuatesspanish
https://www.facebook.com/valuatesjapanese
https://valuatesreportspanish.blogspot.com/
https://valuateskorean.blogspot.com/
https://valuatesgerman.blogspot.com/
https://valuatesreportjapanese.blogspot.com/ 

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/motherboard-market-to-witness-ai-integration–amd-gaming-surge-by-2029–get-free-report–valuates-reports-302459310.html